Effect of Guided Imagery on Anxiety, Depression, and Fatigue in Patients Receiving Hemodialysis
Effect of Guided Imagery on Anxiety, Depression, and Fatigue in Patients Receiving Hemodialysis: A Controlled Trial
This study will evaluate whether a four week guided imagery program, delivered three times per week before hemodialysis, affects anxiety, depression, and fatigue in adults receiving hemodialysis compared with routine care. Measures are planned before the intervention and at the end of week four.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
This study evaluates guided imagery as a supportive nursing intervention for adults receiving hemodialysis. It focuses on anxiety, depression, and fatigue during a four-week intervention period.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Reva GÜNDOĞAN, Assistant Professor
- Phone Number: +905551822097
- Email: r4a5reva@gmail.com
Study Contact Backup
- Name: Sevim Güler, nurse PhD
- Phone Number: +905055894983
- Email: sdegerguler@gmail.com
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria
- Aged 18 years or older
- No cognitive impairment or history of psychiatric illness
- Willing and able to communicate
- Receiving hemodialysis for more than six months
- No hearing, visual, or speech impairment
- Voluntary agreement to participate in the study Exclusion Criteria
- Not receiving regular hemodialysis treatment (dialysis instability)
- Unwilling to participate in the study
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
No Intervention: Control group
Participants in this group will receive routine hemodialysis care without the guided imagery intervention during the four-week study period. |
|
|
Experimental: Guided imagery group
Guided imagery: Patients will undergo guided imagery three times a week for four weeks. Thirty minutes before hemodialysis, patients will be asked to assume a comfortable position, close their eyes, and take deep breaths. Depending on their preference, various nature sounds such as ocean waves, chirping forest birds, or falling rain will be played through over-ear headphones. Patients will then be asked to imagine themselves in the location depicted in the sound recording, using their senses of sight, hearing, smell, and touch. |
Participants will listen to nature sounds through headphones and be guided to imagine the scenes described by the audio, engaging their senses. The intervention will be delivered three times per week for four weeks, 30 minutes before hemodialysis. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hospital Anxiety-Depression Scale-anxiety
Time Frame: Before the application: Follow-up 0 Immediately after the application: Follow-up 1 One month after the application: Follow-up 2
|
HADS : 0 to 21 scores, higher scores indicate worse outcomes. |
Before the application: Follow-up 0 Immediately after the application: Follow-up 1 One month after the application: Follow-up 2
|
|
Hospital Anxiety-Depression Scale-depression
Time Frame: Before the application: Follow-up 0 Immediately after the application: Follow-up 1 One month after the application: Follow-up 2
|
HADS : 0 to 21 scores, higher scores indicate worse outcomes. |
Before the application: Follow-up 0 Immediately after the application: Follow-up 1 One month after the application: Follow-up 2
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Piper Fatigue Scale
Time Frame: Before the application: Follow-up 0 Immediately after the application: Follow-up 1 One month after the application: Follow-up 2
|
PFS: 0 to 230 scores, higher scores indicate worse outcomes. |
Before the application: Follow-up 0 Immediately after the application: Follow-up 1 One month after the application: Follow-up 2
|
Collaborators and Investigators
Sponsor
Sponsor
Publications and helpful links
General Publications
- Beizaee Y, Rejeh N, Heravi-Karimooi M, Tadrisi SD, Griffiths P, Vaismoradi M. The effect of guided imagery on anxiety, depression and vital signs in patients on hemodialysis. Complement Ther Clin Pract. 2018 Nov;33:184-190. doi: 10.1016/j.ctcp.2018.10.008. Epub 2018 Oct 17.
- Bossola M, Hedayati SS, Brys ADH, Gregg LP. Fatigue in Patients Receiving Maintenance Hemodialysis: A Review. Am J Kidney Dis. 2023 Oct;82(4):464-480. doi: 10.1053/j.ajkd.2023.02.008. Epub 2023 May 13.
- Afshar M, Mohsenzadeh A, Gilasi H, Sadeghi-Gandomani H. The effects of guided imagery on state and trait anxiety and sleep quality among patients receiving hemodialysis: A randomized controlled trial. Complement Ther Med. 2018 Oct;40:37-41. doi: 10.1016/j.ctim.2018.07.006. Epub 2018 Jul 11.
Study record dates
Study Major Dates
Study Start (Estimated)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- RG-2026
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
It can be provided upon request from researchers.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.